Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time

被引:87
作者
Abrahamsen, AF [1 ]
Andersen, A
Nome, O
Jacobsen, AB
Holte, H
Abrahamsen, JF
Kvaloy, S
机构
[1] Norwegian Radium Hosp, Dept Med Oncol & Radiotherapy, N-0310 Oslo, Norway
[2] Canc Registry Norway, Oslo, Norway
关键词
Hodgkin's disease; second malignancies;
D O I
10.1093/annonc/mdf289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To quantify the long-term risk of second cancers (SCs) up to 30 years after primary treatment for Hodgkin's disease (HD) Material and methods: In the period 1968 to 1985, an unselected population of 1024 patients started treatment for HD at the Norwegian Radium Hospital (NRH) and were followed for SC from 1969 through 1998 by The Norwegian Cancer Registry. The median age at diagnosis of HD was 40 years, and the median time at follow-up was 14 years. Results: Of 197 SCs, 14 were acute non-lymphocytic leukemia (ANLL), 31 non-Hodgkin's lymphoma (NHL) and 152 solid cancers. The standardized incidence ratio (SIR) was significantly increased for SCs as a group, and for the subgroups ANLL, NHL, lung cancer, breast cancer, stomach cancer and melanoma. ANLL was related to heavy treatment with chemotherapy (CT) and combined CT and radiotherapy (RT), NHL was not treatment related, and solid tumors were related to radiotherapy only or combined RT and CT. The SIR of ANLL and NHL reached a peak between 5 and 10 years after treatment. Solid and non-solid tumors increased with young age at diagnosis of HD and solid tumors increased with follow-up time up to 28 years Conclusion: In a long-term follow-up study of HD patients of all ages, the SIR of solid tumors was high in patients treated at young age and decreased with increasing age. Most solid tumors had started within or at the edge of the irradiated field, and SIR of solid tumors increased even 20-30 years after diagnosis.
引用
收藏
页码:1786 / 1791
页数:6
相关论文
共 25 条
[1]   2ND MALIGNANCIES AFTER TREATMENT OF HODGKINS-DISEASE - THE INFLUENCE OF TREATMENT, FOLLOW-UP TIME, AND AGE [J].
ABRAHAMSEN, JF ;
ANDERSEN, A ;
HANNISDAL, E ;
NOME, O ;
ABRAHAMSEN, AF ;
KVALOY, S ;
HOST, H .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) :255-261
[2]  
Aisenberg AC, 1997, CANCER, V79, P1203, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO
[3]  
2-2
[4]   NONLYMPHOMATOUS MALIGNANT TUMORS COMPLICATING HODGKINS-DISEASE - POSSIBLE ASSOCIATION WITH INTENSIVE THERAPY [J].
ARSENEAU, JC ;
CANELLOS, GP ;
BONNER, H ;
SCHNIPPER, LE ;
SPONZO, RW ;
YOUNG, RC ;
JOHNSON, RE ;
DEVITA, VT ;
LEVIN, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (22) :1119-+
[5]   NON-HODGKINS-LYMPHOMA ARISING IN PATIENTS TREATED FOR HODGKINS-DISEASE IN THE BNLI - A 20-YEAR EXPERIENCE [J].
BENNETT, MH ;
MACLENNAN, KA ;
HUDSON, GV ;
HUDSON, BV .
ANNALS OF ONCOLOGY, 1991, 2 :83-92
[6]   2ND SOLID TUMORS AND LEUKEMIA AFTER TREATMENT FOR HODGKINS-DISEASE - AN ANALYSIS OF 1121 PATIENTS FROM A SINGLE INSTITUTION [J].
BITI, G ;
CELLAI, E ;
MAGRINI, SM ;
PAPI, MG ;
PONTICELLI, P ;
BODDI, V .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (01) :25-31
[7]   INCIDENCE OF 2ND CANCERS IN PATIENTS TREATED FOR HODGKINS-DISEASE [J].
BOIVIN, JF ;
HUTCHISON, GB ;
ZAUBER, AG ;
BERNSTEIN, L ;
DAVIS, FG ;
MICHEL, RP ;
ZANKE, B ;
TAN, CTC ;
FULLER, LM ;
MAUCH, P ;
ULTMANN, JE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (10) :732-741
[8]  
CANELLOS GP, 1975, LANCET, V1, P947
[9]   Second cancers after Hodgkin's disease in childhood [J].
Donaldson, SS ;
Hancock, SL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :792-794
[10]   Current perspectives on radiation-induced breast cancer [J].
Goss, PE ;
Sierra, S .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :338-347